A Cohort Dose-Escalation Phase 1 Study of Intravenous Infusion of Uricase-PEG 20.

Trial Profile

A Cohort Dose-Escalation Phase 1 Study of Intravenous Infusion of Uricase-PEG 20.

Completed
Phase of Trial: Phase I

Latest Information Update: 30 Apr 2010

At a glance

  • Drugs Pegadricase (Primary)
  • Indications Gout; Hyperuricaemia
  • Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
  • Most Recent Events

    • 30 Apr 2010 Top-line results have been presented in an EnzymeRx media release.
    • 23 Feb 2010 Status changed from recruiting to completed according to EnzymeRx media release.
    • 09 Dec 2009 Planned number of patients (20) and official title added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top